改良无痛光动力疗法治疗中国面部多发性光化性角化病:一项前瞻性分面对照研究。

IF 2.2 3区 医学 Q2 DERMATOLOGY
Jiandan Li MM, Yunfeng Zhang MD, Guolong Zhang MD, PhD, Linglin Zhang MD, Zhongxia Zhou, Peiru Wang MD, PhD, Xiuli Wang MD, PhD
{"title":"改良无痛光动力疗法治疗中国面部多发性光化性角化病:一项前瞻性分面对照研究。","authors":"Jiandan Li MM,&nbsp;Yunfeng Zhang MD,&nbsp;Guolong Zhang MD, PhD,&nbsp;Linglin Zhang MD,&nbsp;Zhongxia Zhou,&nbsp;Peiru Wang MD, PhD,&nbsp;Xiuli Wang MD, PhD","doi":"10.1002/lsm.23728","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Aminolevulinic acid photodynamic therapy (ALA-PDT) is an effective treatment for multiple actinic keratosis (AK). However, PDT-induced pain often discontinues the therapy to reduce its efficacy, limiting its application. If modified painless PDT schedule with shorter photosensitizer dressing and higher dose illumination could achieve good efficacy in AK, it is still unknown.</p>\n </section>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>To explore the efficacy and pain tolerance of the modified painless PDT (M-PDT) in facial multiple AK.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A split-face controlled clinical study including 14 patients with facial multiple AK was conducted. The patients received conventional PDT (C-PDT) on the left and M-PDT in the contralateral area. The left area (C-PDT) was illuminated by a red light-emitting diode light (144 J/cm<sup>2</sup>) after applying the 10% ALA cream for 3 h; the other had illumination for a total light dose of 288 J/cm<sup>2</sup> after applying the 10% ALA cream for 0.5 h. The primary endpoint was the lesion clearance rate at 1-month postthree sessions of PDT. Secondary endpoints included pain scores, the incidence of adverse events during treatment, and cosmetic outcomes.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>At 1 month following three treatments, the total lesion clearance rate was comparable between M-PDT and C-PDT (91.6% vs. 89.0%). While the lesion clearance rate of M-PDT was higher than that of C-PDT in the Grade III lesions (86.5% vs. 72.0%, respectively) (<i>p</i> &lt; 0.05). M-PDT achieved a 100% lesion clearance rate for Grade I lesions earlier than C-PDT, with M-PDT treated twice and C-PDT treated thrice. Moreover, the pain score during illumination was significantly lower for M-PDT than for C-PDT (<i>p</i> &lt; 0.01). Regarding photoaging, the Global Subjective Skin Aging Assessment score showed that the total and atrophy scores of C-PDT and M-PDT were significantly improved, and M-PDT also reduced discoloration. There was no significant difference in adverse reactions between C-PDT and M-PDT.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>M-PDT is comparable to C-PDT's efficacy for treating facial multiple AK, resulting in much lower pain scores.</p>\n </section>\n </div>","PeriodicalId":17961,"journal":{"name":"Lasers in Surgery and Medicine","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split-face control study\",\"authors\":\"Jiandan Li MM,&nbsp;Yunfeng Zhang MD,&nbsp;Guolong Zhang MD, PhD,&nbsp;Linglin Zhang MD,&nbsp;Zhongxia Zhou,&nbsp;Peiru Wang MD, PhD,&nbsp;Xiuli Wang MD, PhD\",\"doi\":\"10.1002/lsm.23728\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Aminolevulinic acid photodynamic therapy (ALA-PDT) is an effective treatment for multiple actinic keratosis (AK). However, PDT-induced pain often discontinues the therapy to reduce its efficacy, limiting its application. If modified painless PDT schedule with shorter photosensitizer dressing and higher dose illumination could achieve good efficacy in AK, it is still unknown.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Objectives</h3>\\n \\n <p>To explore the efficacy and pain tolerance of the modified painless PDT (M-PDT) in facial multiple AK.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>A split-face controlled clinical study including 14 patients with facial multiple AK was conducted. The patients received conventional PDT (C-PDT) on the left and M-PDT in the contralateral area. The left area (C-PDT) was illuminated by a red light-emitting diode light (144 J/cm<sup>2</sup>) after applying the 10% ALA cream for 3 h; the other had illumination for a total light dose of 288 J/cm<sup>2</sup> after applying the 10% ALA cream for 0.5 h. The primary endpoint was the lesion clearance rate at 1-month postthree sessions of PDT. Secondary endpoints included pain scores, the incidence of adverse events during treatment, and cosmetic outcomes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>At 1 month following three treatments, the total lesion clearance rate was comparable between M-PDT and C-PDT (91.6% vs. 89.0%). While the lesion clearance rate of M-PDT was higher than that of C-PDT in the Grade III lesions (86.5% vs. 72.0%, respectively) (<i>p</i> &lt; 0.05). M-PDT achieved a 100% lesion clearance rate for Grade I lesions earlier than C-PDT, with M-PDT treated twice and C-PDT treated thrice. Moreover, the pain score during illumination was significantly lower for M-PDT than for C-PDT (<i>p</i> &lt; 0.01). Regarding photoaging, the Global Subjective Skin Aging Assessment score showed that the total and atrophy scores of C-PDT and M-PDT were significantly improved, and M-PDT also reduced discoloration. There was no significant difference in adverse reactions between C-PDT and M-PDT.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>M-PDT is comparable to C-PDT's efficacy for treating facial multiple AK, resulting in much lower pain scores.</p>\\n </section>\\n </div>\",\"PeriodicalId\":17961,\"journal\":{\"name\":\"Lasers in Surgery and Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2023-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lasers in Surgery and Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/lsm.23728\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lasers in Surgery and Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/lsm.23728","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:氨基乙酰丙酸光动力疗法(ALA-PDT)是治疗多发性光化性角化病(AK)的有效方法。然而,PDT引起的疼痛通常会中断治疗以降低其疗效,从而限制其应用。改良的无痛PDT方案,更短的光敏剂敷料和更高剂量的光照,是否能在AK中获得良好的疗效,目前尚不清楚。目的:探讨改良无痛PDT(M-PDT)治疗面部多发性AK的疗效和疼痛耐受性。患者在左侧接受常规PDT(C-PDT),在对侧接受M-PDT。左侧区域(C-PDT)由红色发光二极管照明(144 J/cm2) h;另一个的照明总剂量为288 在施用10%ALA乳膏0.5天后J/cm2 h.主要终点是PDT三个疗程后1个月的病变清除率。次要终点包括疼痛评分、治疗期间不良事件的发生率和美容效果。结果:在三种治疗后1个月,M-PDT和C-PDT的总病灶清除率相当(91.6%对89.0%),而M-PDT在III级病灶中的病灶清除率高于C-PDT(86.5%对72.0%)(p 结论:M-PDT治疗面部多发性AK的疗效与C-PDT相当,导致疼痛评分低得多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split-face control study

Background

Aminolevulinic acid photodynamic therapy (ALA-PDT) is an effective treatment for multiple actinic keratosis (AK). However, PDT-induced pain often discontinues the therapy to reduce its efficacy, limiting its application. If modified painless PDT schedule with shorter photosensitizer dressing and higher dose illumination could achieve good efficacy in AK, it is still unknown.

Objectives

To explore the efficacy and pain tolerance of the modified painless PDT (M-PDT) in facial multiple AK.

Methods

A split-face controlled clinical study including 14 patients with facial multiple AK was conducted. The patients received conventional PDT (C-PDT) on the left and M-PDT in the contralateral area. The left area (C-PDT) was illuminated by a red light-emitting diode light (144 J/cm2) after applying the 10% ALA cream for 3 h; the other had illumination for a total light dose of 288 J/cm2 after applying the 10% ALA cream for 0.5 h. The primary endpoint was the lesion clearance rate at 1-month postthree sessions of PDT. Secondary endpoints included pain scores, the incidence of adverse events during treatment, and cosmetic outcomes.

Results

At 1 month following three treatments, the total lesion clearance rate was comparable between M-PDT and C-PDT (91.6% vs. 89.0%). While the lesion clearance rate of M-PDT was higher than that of C-PDT in the Grade III lesions (86.5% vs. 72.0%, respectively) (p < 0.05). M-PDT achieved a 100% lesion clearance rate for Grade I lesions earlier than C-PDT, with M-PDT treated twice and C-PDT treated thrice. Moreover, the pain score during illumination was significantly lower for M-PDT than for C-PDT (p < 0.01). Regarding photoaging, the Global Subjective Skin Aging Assessment score showed that the total and atrophy scores of C-PDT and M-PDT were significantly improved, and M-PDT also reduced discoloration. There was no significant difference in adverse reactions between C-PDT and M-PDT.

Conclusions

M-PDT is comparable to C-PDT's efficacy for treating facial multiple AK, resulting in much lower pain scores.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.40
自引率
12.50%
发文量
119
审稿时长
1 months
期刊介绍: Lasers in Surgery and Medicine publishes the highest quality research and clinical manuscripts in areas relating to the use of lasers in medicine and biology. The journal publishes basic and clinical studies on the therapeutic and diagnostic use of lasers in all the surgical and medical specialties. Contributions regarding clinical trials, new therapeutic techniques or instrumentation, laser biophysics and bioengineering, photobiology and photochemistry, outcomes research, cost-effectiveness, and other aspects of biomedicine are welcome. Using a process of rigorous yet rapid review of submitted manuscripts, findings of high scientific and medical interest are published with a minimum delay.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信